Payments to Acquire Property, Plant, and Equipment of Summit Therapeutics Inc. from 31 Jan 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Summit Therapeutics Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Jan 2018 to 31 Dec 2025.
  • Summit Therapeutics Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $422,000, a 10450% increase year-over-year.
  • Summit Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $657,000, a 373% increase from 2024.
  • Summit Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $139,000, a 8.6% increase from 2023.
  • Summit Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $128,000, a 79% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Summit Therapeutics Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $657,000 +$518,000 +373% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $139,000 +$11,000 +8.6% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $128,000 -$496,000 -79% 01 Jan 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
2022 $624,000 +$318,000 +104% 01 Jan 2022 31 Dec 2022 10-K 24 Feb 2025 2024 FY
2021 $306,000 -$115,000 -27% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $421,000 +$216,000 +105% 01 Jan 2020 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
2019 $205,000 +$48,000 +31% 01 Feb 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $157,000 -$511,000 -76% 01 Feb 2018 31 Jan 2019 10-K 31 Mar 2021 2020 FY
2017 $668,000 01 Feb 2017 31 Jan 2018 8-K 29 Sep 2020 2020 Q2

Summit Therapeutics Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $422,000 +$418,000 +10450% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $4,000 -$49,000 -92% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $53,000 -$308,000 -85% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $361,000 +$322,000 +826% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $39,000 +$9,000 +30% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $30,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.